Sheffield Pharmaceuticals, Inc., which combines state-of-the-art pulmonary drug delivery technologies with existing and emerging therapeutic agents, announced the issuance of the fourth U.S. patent ...
A new trial at Sheffield Children's Hospital will test whether a combined inhaler can better control asthma symptoms and attacks in youngsters. The study, which focuses on children aged six to 11, ...